[Determining the possibility of collecting reliable data for use in decision making in health care on the example of cost-effectiveness analysis of methods used in smoking cessation].
Reports on Polish Health care system found that the evidence from systematic reviews and cost-effectiveness analyses is not sufficiently used in decision-making. The aim of this study was to determine the possibility of reliable cost and other data collection in Poland to inform cost-effectiveness analysis of smoking cessation methods in Poland, which could be used to support decisions from the perspective of National Health Fund. In order to estimate long term effects of smoking cessation Markov model was built. Direct medical costs of the following smoking related diseases were sought: chronic obstructive pulmonary disease, coronary heart disease, lung cancer and stroke. Analysis was performed from National Health Fund perspective. Published cost data were insufficient for the analysis, so an attempt was made to obtain cost data from National Insurance Fund, which was not very successful due to their lack. Mortality data were obtained from National Office of Statistics. Lung cancer incidence and mortality were obtained from national register. No registries systematically and routinely collecting incidence and prevalence data for other diseases were localized. No studies exploring utilities of Polish population in the analyzed health states were found. As no disease registries, except for cancer, systematically collecting epidemiologic data and no unified system of collecting cost data were found, less reliable data has to be used in cost-effectiveness analyses supporting the decisions in health care in Poland.